Castle Biosciences, Inc. Stock News

Castle announced the publication of a clinical utility model for its cutaneous squamous cell carcinoma (SCC) prognostic test, DecisionDx®-SCC.

Castle today announced the publication of development and validation data for DecisionDx®-SCC.

As of late, it has definitely been a great time to be an investor in Castle Biosciences.

Castle Biosciences announced that it will release its financial results for the first quarter 2020, after the close of market on Monday, May 11, 2020.

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Castle is scheduled to present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020, at 3:30 p.m. Eastern.

Castle today announced that Miles Harrison has been appointed to the board of directors, effective immediately.

Castle announced the publication of a systematic review and meta-analysis in JAAD.

Castle Posts Results of Collaborative Ocular Oncology Group Survey on the Management of Ocular Oncology Patients During the COVID-19 Pandemic.

Castle Announces Publication of Fourth Study Demonstrating Significant Impact of DecisionDx-UM on Treatment Plan Recommendations.

Castle Biosciences (NASDAQ:CSTL) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their divid

Castle Biosciences (NASDAQ:CSTL) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their insti

Castle announced its financial results for the fourth quarter and twelve months ended December 31, 2019.

NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Castle Biosciences Inc (NASDAQ:CSTL) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at 4

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis...